Inhibrx Biosciences, Inc DEFA14A, filed Apr 16, 2025

Inhibrx Biosciences, Inc. (INBX)

DEFA14A 2025-04-16

Added on October 14, 2026


UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

			SCHEDULE 14A
			(RULE 14A-101)
			Schedule 14A INFORMATION

			Proxy Statement Pursuant to Section 14(a)
of the Securities Exchange Act of 1934 (Amendment No. )


Check the appropriate box:
☐						Preliminary Proxy Statement
☐						Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
☐						Definitive Proxy Statement
☒						Definitive Additional Materials
☐						Soliciting Material Pursuant to §240.14a-12


Payment of Filing Fee (Check all boxes that apply):
☒						No fee required.











☐						Fee paid previously with preliminary materials.
☐						Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.



INHIBRX BIOSCIENCES, INC.
(Name of Registrant as Specified In Its Charter)


(Name of Person(s) Filing Proxy Statement, if other than the Registrant)